# The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.

> **NCT02942615** · NA · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 220 (estimated)

## Conditions studied

- Breast Neoplasms
- Cardiotoxicity

## Interventions

- **OTHER:** limit heart dose

## Key facts

- **NCT ID:** NCT02942615
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-27
- **Primary completion:** 2020-10-08
- **Final completion:** 2025-10
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2022-12-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02942615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02942615, "The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02942615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*